Ep. 05 | CMV Cell Mediated Immunity, a recent White Paper and our CMV T Cell Immunity Panel.
Eurofins Viracor | Clinical Diagnostics Talk
by Eurofins Viracor
3y ago
This episode discusses CMV cell mediated immunity and the recently released white paper evaluating various methodologies, including Viracor’s CMV T Cell Immunity Panel. Episode Links: Eurofins Viracor CMV information Eurofins Viracor CMV T Cell Immunity Panel View our product theater presented during TCT 2021 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR "Post-Transplant Prevention and Management of Cytomegalovirus" Social Media: Linkedin   |   Twitter   |   Facebook For more information visit: Viracor-Eurofins.com or call (800)305 ..read more
Visit website
Ep. 04 | Immuknow - An assay designed to detect changes in immune cell function over time.
Eurofins Viracor | Clinical Diagnostics Talk
by Eurofins Viracor
3y ago
This episode discusses solid organ transplantation and the use of FDA approved Eurofins-Viracor ImmuKnow® assay for non-invasive testing to screen for indicators of infection or transplanted tissue rejection. Episode Links: ImmuKnow® Immune Cell Function Assay. ImmuKnow® Assay test menu. ImmuKnow® in the newsroom. Social Media: Linkedin   |   Twitter   |   Facebook For more information visit: Viracor-Eurofins.com or call (800)305-5198   ..read more
Visit website
Ep. 03 | GVHD - Graft Versus Host Disease and our suite of aGVHD diagnostic tests.
Eurofins Viracor | Clinical Diagnostics Talk
by Eurofins Viracor
3y ago
Graft Versus Host Disease (GVHD), a recently published white paper by Dr. Steve Kleiboeker and the Eurofins-Viracor suite of tests for acute Graft Versus Host Disease: aGVHD Pre-Symptomatic Algorithm, aGVHD Symptomatic Algorithm, and aGVHD Post-Treatment Algorithm. Episode Links: Dr. Kleiboeker's white paper: Diagnostic Methods to Predict Outcomes for Acute Graft Versus Host Disease in Allogeneic Hematopoietic Cell Transplant Recipients Eurofins Viracor aGVHD Pre-Symptomatic Algorithm Eurofins Viracor aGVHD suite of tests Register for our product theater at #TCTM21 Abstract #102 Free Webinar ..read more
Visit website
Ep. 02 | Labs@Home, a mobile phlebotomy solution for your at-risk patients.
Eurofins Viracor | Clinical Diagnostics Talk
by Eurofins Viracor
3y ago
As the hospital system becomes increasingly stressed with COVID-19 patients, at-risk patients are increasingly in danger of infection which can possibly lead to even more severe issues. Learn how our mobile phlebotomy solution, Labs@Home can help your most at-risk patients receive the lab draws and testing they need from the convenience of their home. Episode Links: CDC: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/immunocompromised.html Trugraf® by Transplant Genomics  |  About Trugraf: www.trugraf.com/trugraf/ Labs@Home Press Release  |  Labs@Home VID ..read more
Visit website
Ep. 01 | COVID-19 or Flu? Our test can help distinguish between overlapping symptoms.
Eurofins Viracor | Clinical Diagnostics Talk
by Eurofins Viracor
3y ago
In our first episode we discuss our new combined test for SARS-CoV-2, Influenza A & B. This can help distinguish between multiple respiratory pathogens that exhibit overlapping symptoms and assist in treatment decisions for your patients. The combined SARS-CoV-2 Plus Flu A/B tests are intended for the qualitative detection of SARS-CoV-2 and the quantitative detection of Influenza A, Influenza B. Episode Links: www.cdc.gov/flu/weekly/ www.cdc.gov/flu/season/faq-flu-season-2020-2021.htm#Flu-and-COVID-19/ www.viracor-eurofins.com/test-menu/sars-cov-2-plus-quantitative-flu-a-flu-b-rt-pcr Socia ..read more
Visit website

Follow Eurofins Viracor | Clinical Diagnostics Talk on FeedSpot

Continue with Google
Continue with Apple
OR